← Leaderboards
Ludo Van Den Bosch
University Of Illinois At Chicago
$947,449
Attributed
$1,894,898
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $398.2K · FY2013–17$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$1,894,898 · 1
By mechanism
R01$1,894,898 · 1
Top collaborators
- Alan P. Kozikowski5 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Alan P. Kozikowski$10,594,236
Others in their field
Top investigators on “Adolescence”
- Lawrence Corey · Fred Hutchinson Cancer Center$481,946,630
- Gregory H Reaman · National Childhood Cancer Foundation$264,737,004
- Barbara Driver · Westat, Inc.$232,205,725
- George R Seage · Abt Associates, Inc.$222,555,872
- Sharon A Nachman · Johns Hopkins University$213,337,729
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$198,115,770
Research focus
AdolescenceAdultAffectAfferent NerveAge-MonthsAnalogAnimal ModelAnimalsAxonAxonal TransportAxonopathyBehaviorCellsCharacteristicsCharcot-Marie-Tooth DiseaseClawClinicComputer SimulationDeacetylationDefectDeformityDesignDisease PhenotypeAcetylation
Grant awards (5)
Optimization of HDAC6 Inhibitors in the Treatment of CMT$352,668
R01 · FY2017 · NS
Optimization of HDAC6 Inhibitors in the Treatment of CMT$384,147
R01 · FY2016 · NS
Optimization of HDAC6 Inhibitors in the Treatment of CMT$377,734
R01 · FY2015 · NS
Optimization of HDAC6 Inhibitors in the Treatment of CMT$382,123
R01 · FY2014 · NS
Optimization of HDAC6 Inhibitors in the Treatment of CMT$398,226
R01 · FY2013 · NS